TLP
Tri Locum Partners’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.5M | Buy |
147,642
+115,317
| +357% | +$19.9M | 7.73% | 5 |
|
|
2025
Q1 | $5.04M | Buy |
+32,325
| New | +$5.04M | 2.59% | 15 |
|
|
2024
Q3 | – | Sell |
-227,762
| Closed | -$31.1M | – | 23 |
|
|
2024
Q2 | $31.1M | Buy |
227,762
+115,092
| +102% | +$15.7M | 7.85% | 3 |
|
|
2024
Q1 | $17M | Buy |
112,670
+13,120
| +13% | +$1.98M | 5.91% | 5 |
|
|
2023
Q4 | $12.5M | Buy |
+99,550
| New | +$12.5M | 5.73% | 5 |
|
|
2023
Q1 | – | Sell |
-99,215
| Closed | -$12.1M | – | 52 |
|
|
2022
Q4 | $12.1M | Buy |
+99,215
| New | +$12.1M | 4.9% | 7 |
|